A phase 2 study of endoxifen in breast cancer patients who are refractory to tamoxifen
Latest Information Update: 11 Sep 2020
At a glance
- Drugs Endoxifen (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 13 Jul 2018 According to an Atossa Genetics media release, the company expects to initiate this study in H2 2018.
- 28 Dec 2017 According to an Atossa Genetics media release, the company expects to initiate this study in the first quarter of 2018 and the company plans to complete the study in 2018.
- 11 May 2017 According to an Atossa Genetics medi release, the company anticipates commencing a this phase 2 study in the second half of 2017.